Natriuretic Peptide Measurement Is Key to a Solution in the Clinical Trial and Clinical Practice.

In this issue of JACC: Heart Failure , Jonathan et al. ([1][1]) analyzed the data from the COMMANDER-HF (A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease